IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses

$2,300,000U01FY2023IPCDC

Seattle Children'S Hospital, Seattle WA

Investigators

Janet A Englundcontact Eileen Klein

Linked publications & trials

Paper 38457312 Paper 38366649 Paper 38298053 Paper 36749589 Paper 36201373 Paper 34951451 Paper 34704375 Paper 34643241

View original record on NIH RePORTER →